Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2417 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

23 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2020-11-19 2021-01-28 128597
TEVA-DEXTROAMPHETAMINE SR 10MG CAPSULE (SUSTAINED-RELEASE) Resolved 2020-12-10 2021-01-28 129978
TEVA-DEXTROAMPHETAMINE SR 10MG CAPSULE (SUSTAINED-RELEASE) Resolved 2021-03-25 2021-05-06 136292
TEVA-DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2022-03-04 2022-03-24 156064
TEVA-DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2022-08-18 2022-10-18 167182
TEVA-DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2022-12-01 2022-12-22 176821
TEVA-DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2023-02-09 2023-06-09 184225
TEVA-DEXTROAMPHETAMINE SR 10MG CAPSULE (SUSTAINED-RELEASE) Resolved 2023-04-27 2023-06-09 190731
TEVA-DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2024-01-25 2024-04-25 217240
TEVA-DEXTROAMPHETAMINE SR 10MG CAPSULE (SUSTAINED-RELEASE) Resolved 2024-02-01 2024-04-25 218145
ACT DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Resolved 2017-05-10 2017-09-19 9901
ACT DILTIAZEM CD 300MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2023-04-28 61340
ACT DILTIAZEM CD Actual shortage 2018-12-04 2018-12-04 68602
ACT DILTIAZEM CD 120MG CAPSULE (EXTENDED RELEASE) Resolved 2019-04-26 2021-05-26 82552
ACT DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Resolved 2019-04-26 2021-05-26 82555
ACT DILTIAZEM T 360MG CAPSULE (EXTENDED RELEASE) Resolved 2017-03-17 2018-10-11 3362
ACT ENALAPRIL 4MG TABLET Resolved 2017-08-24 2017-10-10 20315
ACT ENALAPRIL 16MG TABLET Resolved 2017-08-24 2017-10-10 20326
ACT ENALAPRIL 8MG TABLET Resolved 2018-09-12 2019-03-12 61343
ACT ENALAPRIL 2MG TABLET Resolved 2018-09-12 2019-01-31 61346

Showing 61 to 80 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
EPIRUBICIN FOR INJECTION 2MG SOLUTION Discontinued 2020-10-22 2020-10-24 126906
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393

Showing 61 to 80 of 250